APA

Ferro R., Adamska A., Lattanzio R., Mavrommati I., Edling C. E., Arifin S. A., Fyffe C. A., Sala G., Sacchetto L., Chiorino G., De Laurenzi V., Piantelli M., Sansom O. J., Maffucci T. & Falasca M. (20190228). GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. : Oncogene.

Chicago

Ferro R, Adamska A, Lattanzio R, Mavrommati I, Edling C E, Arifin S A, Fyffe C A, Sala G, Sacchetto L, Chiorino G, De Laurenzi V, Piantelli M, Sansom O J, Maffucci T and Falasca M. 20190228. GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. : Oncogene.

Harvard

Ferro R., Adamska A., Lattanzio R., Mavrommati I., Edling C. E., Arifin S. A., Fyffe C. A., Sala G., Sacchetto L., Chiorino G., De Laurenzi V., Piantelli M., Sansom O. J., Maffucci T. and Falasca M. (20190228). GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. : Oncogene.

MLA

Ferro R, Adamska A, Lattanzio R, Mavrommati I, Edling C E, Arifin S A, Fyffe C A, Sala G, Sacchetto L, Chiorino G, De Laurenzi V, Piantelli M, Sansom O J, Maffucci T and Falasca M. GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. : Oncogene. 20190228.